3 results match your criteria: "University of Geneva and Institute of Genetics and Genomics in Geneva (iGE3)[Affiliation]"
Hamostaseologie
March 2025
Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva and Institute of Genetics and Genomics in Geneva (iGE3), Geneva, Switzerland.
Congenital fibrinogen deficiencies (CFDs), traditionally considered rare monogenic disorders, are now recognized as more prevalent and genetically complex than previously thought. Indeed, the symptoms manifested in CFD patients, such as bleeding and thrombosis, are likely to result from variation in several genes rather than solely driven by variants in one of the three fibrinogen genes, , , and . This review highlights recent advances in understanding the genetic causes of CFD and their variability, facilitated by the growing use and availability of next-generation sequencing data.
View Article and Find Full Text PDFHLA
December 2023
Medical Affairs & Innovation, Héma-Québec, Montréal, Quebec, Canada.
As part of the worldwide effort to better characterize HLA diversity in populations, we have studied the population of Québec in Canada. This province has been defined by a complex history with multiple founder effects and migration patterns. We analyzed the typing data of 3806 individuals registered in Héma-Québec's Registry, which covered most administrative regions in Québec.
View Article and Find Full Text PDFHum Immunol
January 2019
Department of Genetics and Evolution - Anthropology Unit, University of Geneva and Institute of Genetics and Genomics in Geneva (IGE3), Switzerland. Electronic address:
This paper discusses the advantages provided by next generation sequencing (NGS) compared to traditional typings or limited sequencing strategies for the characterization of HLA population diversity based on four documented examples. We also comment the limitations of this approach by highlighting pitfalls in interpreting NGS data.
View Article and Find Full Text PDF